Montelukast Prescribing at QUEEN MARY PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
213
Total Quantity
5,852
NHS Cost
£544
vs National Avg
-68.9%
QUEEN MARY PRACTICE prescribed 213 items of Montelukast over the last 12 months at a cost of £544 to the NHS. This is 68.9% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
17
Jul 2026
23
Jul 2026
24
Jul 2026
19
Jul 2026
18
Jul 2026
19
Jul 2026
16
Jul 2026
15
Jul 2026
13
Jul 2026
17
Jul 2026
17
Jul 2026
15
Prescribing Details
| Total Items | 213 |
|---|---|
| Total Quantity | 5,852 |
| Total NHS Cost | £544 |
| Presentations | 5 different forms |
| vs National Average | -68.9% |
Montelukast Prescribing Comparison
| This practice | 213 items |
|---|---|
| National average per practice | 685 items |
| Difference | -68.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.